Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 11479 | 10.45 |
09:34 ET | 2803 | 10.41 |
09:36 ET | 1376 | 10.36 |
09:38 ET | 11088 | 10.43 |
09:39 ET | 1416 | 10.43 |
09:41 ET | 2001 | 10.4 |
09:43 ET | 2435 | 10.42 |
09:45 ET | 600 | 10.385 |
09:48 ET | 4871 | 10.35 |
09:50 ET | 910 | 10.35 |
09:52 ET | 43036 | 10.32 |
09:54 ET | 2722 | 10.325 |
09:56 ET | 1324 | 10.32 |
09:57 ET | 86177 | 10.25 |
09:59 ET | 2481 | 10.23 |
10:01 ET | 1497 | 10.215 |
10:03 ET | 5849 | 10.33 |
10:06 ET | 2300 | 10.36 |
10:08 ET | 1700 | 10.38 |
10:10 ET | 1735 | 10.41 |
10:12 ET | 4769 | 10.48 |
10:14 ET | 2463 | 10.51 |
10:15 ET | 300 | 10.505 |
10:17 ET | 2377 | 10.4752 |
10:19 ET | 2413 | 10.48 |
10:21 ET | 4100 | 10.5 |
10:24 ET | 3430 | 10.5189 |
10:26 ET | 9218 | 10.48 |
10:28 ET | 2710 | 10.51 |
10:30 ET | 1000 | 10.495 |
10:32 ET | 1695 | 10.475 |
10:33 ET | 3003 | 10.435 |
10:35 ET | 1205 | 10.44 |
10:37 ET | 300 | 10.435 |
10:39 ET | 2313 | 10.405 |
10:42 ET | 1718 | 10.39 |
10:44 ET | 655 | 10.37 |
10:46 ET | 4012 | 10.38 |
10:48 ET | 46772 | 10.32 |
10:50 ET | 2805 | 10.24 |
10:51 ET | 3444 | 10.21 |
10:53 ET | 1853 | 10.21 |
10:55 ET | 1404 | 10.22 |
10:57 ET | 300 | 10.225 |
11:00 ET | 2575 | 10.18 |
11:02 ET | 4331 | 10.2012 |
11:04 ET | 200 | 10.195 |
11:06 ET | 800 | 10.19 |
11:08 ET | 2191 | 10.22 |
11:09 ET | 1300 | 10.195 |
11:11 ET | 2906 | 10.17 |
11:13 ET | 1600 | 10.155 |
11:15 ET | 6929 | 10.14 |
11:18 ET | 1305 | 10.14 |
11:20 ET | 3730 | 10.165 |
11:22 ET | 1200 | 10.165 |
11:24 ET | 1926 | 10.165 |
11:26 ET | 1708 | 10.175 |
11:27 ET | 1935 | 10.19 |
11:29 ET | 2798 | 10.235 |
11:31 ET | 5215 | 10.265 |
11:33 ET | 5254 | 10.245 |
11:36 ET | 700 | 10.27 |
11:38 ET | 1978 | 10.275 |
11:40 ET | 2523 | 10.295 |
11:42 ET | 1104 | 10.315 |
11:44 ET | 2100 | 10.34 |
11:45 ET | 1901 | 10.35 |
11:47 ET | 1100 | 10.34 |
11:49 ET | 4817 | 10.375 |
11:51 ET | 1493 | 10.39 |
11:54 ET | 2064 | 10.405 |
11:56 ET | 3070 | 10.395 |
11:58 ET | 2574 | 10.385 |
12:00 ET | 3360 | 10.37 |
12:02 ET | 5740 | 10.4 |
12:03 ET | 3107 | 10.425 |
12:05 ET | 824 | 10.41 |
12:07 ET | 761 | 10.4 |
12:09 ET | 2652 | 10.37 |
12:12 ET | 364 | 10.37 |
12:14 ET | 1130 | 10.365 |
12:16 ET | 2797 | 10.3 |
12:18 ET | 3964 | 10.252 |
12:20 ET | 4373 | 10.275 |
12:21 ET | 670 | 10.27 |
12:23 ET | 800 | 10.25 |
12:25 ET | 2609 | 10.255 |
12:27 ET | 4997 | 10.29 |
12:30 ET | 470 | 10.285 |
12:32 ET | 1719 | 10.285 |
12:34 ET | 628 | 10.265 |
12:36 ET | 1400 | 10.265 |
12:38 ET | 6720 | 10.28 |
12:39 ET | 1000 | 10.28 |
12:41 ET | 970 | 10.275 |
12:43 ET | 4014 | 10.25 |
12:45 ET | 200 | 10.255 |
12:48 ET | 1670 | 10.245 |
12:50 ET | 740 | 10.22 |
12:52 ET | 4125 | 10.215 |
12:54 ET | 941 | 10.21 |
12:56 ET | 1584 | 10.21 |
12:57 ET | 600 | 10.215 |
12:59 ET | 1841 | 10.235 |
01:01 ET | 1168 | 10.25 |
01:03 ET | 2142 | 10.26 |
01:06 ET | 507 | 10.255 |
01:08 ET | 511 | 10.265 |
01:10 ET | 2421 | 10.29 |
01:12 ET | 400 | 10.295 |
01:14 ET | 500 | 10.29 |
01:15 ET | 1355 | 10.3 |
01:17 ET | 2541 | 10.32 |
01:19 ET | 100 | 10.325 |
01:24 ET | 4656 | 10.355 |
01:26 ET | 600 | 10.37 |
01:28 ET | 1018 | 10.37 |
01:30 ET | 1939 | 10.39 |
01:32 ET | 1406 | 10.375 |
01:33 ET | 5178 | 10.36 |
01:35 ET | 1153 | 10.375 |
01:37 ET | 6940 | 10.335 |
01:39 ET | 2700 | 10.355 |
01:42 ET | 800 | 10.37 |
01:44 ET | 707 | 10.365 |
01:46 ET | 2085 | 10.38 |
01:48 ET | 5464 | 10.32 |
01:50 ET | 1101 | 10.315 |
01:51 ET | 2475 | 10.285 |
01:53 ET | 3392 | 10.305 |
01:55 ET | 900 | 10.31 |
01:57 ET | 1200 | 10.315 |
02:00 ET | 3186 | 10.285 |
02:02 ET | 6556 | 10.3 |
02:04 ET | 600 | 10.3 |
02:06 ET | 100 | 10.295 |
02:08 ET | 2998 | 10.28 |
02:09 ET | 1000 | 10.275 |
02:11 ET | 2613 | 10.27 |
02:13 ET | 2200 | 10.27 |
02:15 ET | 512 | 10.265 |
02:18 ET | 1650 | 10.26 |
02:20 ET | 2275 | 10.235 |
02:22 ET | 4949 | 10.24 |
02:24 ET | 1200 | 10.24 |
02:26 ET | 4490 | 10.265 |
02:27 ET | 100 | 10.265 |
02:29 ET | 1094 | 10.255 |
02:31 ET | 2994 | 10.24 |
02:33 ET | 1218 | 10.225 |
02:36 ET | 617 | 10.225 |
02:38 ET | 3566 | 10.195 |
02:40 ET | 1914 | 10.18 |
02:42 ET | 4832 | 10.175 |
02:44 ET | 5011 | 10.18 |
02:45 ET | 900 | 10.171 |
02:47 ET | 3545 | 10.195 |
02:49 ET | 597 | 10.185 |
02:51 ET | 8687 | 10.225 |
02:54 ET | 2138 | 10.23 |
02:56 ET | 4753 | 10.26 |
02:58 ET | 7715 | 10.235 |
03:00 ET | 1052 | 10.235 |
03:02 ET | 8059 | 10.25 |
03:03 ET | 1086 | 10.265 |
03:05 ET | 4843 | 10.29 |
03:07 ET | 600 | 10.295 |
03:09 ET | 3523 | 10.305 |
03:12 ET | 2528 | 10.285 |
03:14 ET | 2810 | 10.255 |
03:16 ET | 1000 | 10.245 |
03:18 ET | 2820 | 10.24 |
03:20 ET | 3052 | 10.235 |
03:21 ET | 2280 | 10.22 |
03:23 ET | 1117 | 10.215 |
03:25 ET | 2901 | 10.195 |
03:27 ET | 7190 | 10.17 |
03:30 ET | 1400 | 10.185 |
03:32 ET | 11647 | 10.195 |
03:34 ET | 900 | 10.205 |
03:36 ET | 2932 | 10.2213 |
03:38 ET | 1400 | 10.2073 |
03:39 ET | 1509 | 10.205 |
03:41 ET | 1203 | 10.205 |
03:43 ET | 9885 | 10.225 |
03:45 ET | 6062 | 10.24 |
03:48 ET | 4274 | 10.225 |
03:50 ET | 10403 | 10.25 |
03:52 ET | 9600 | 10.21 |
03:54 ET | 7197 | 10.205 |
03:56 ET | 20159 | 10.21 |
03:57 ET | 30577 | 10.205 |
03:59 ET | 35112 | 10.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.4B | -2.5x | --- |
Prothena Corporation PLC | 1.3B | -8.5x | --- |
Arcus Biosciences Inc | 1.5B | -3.8x | --- |
Protagonist Therapeutics Inc | 1.5B | -17.8x | --- |
Immatics NV | 1.1B | -8.3x | --- |
4D Molecular Therapeutics Inc | 1.4B | -10.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 17.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.